The General Research Grant from FARA funds innovative basic, translational, and clinical research to advance understanding and treatment of Friedreich’s ataxia.
Funder: Friedreich's Ataxia Research Alliance
Due Dates: August 15, 2026 (LOI, 2nd round) | October 15, 2026 (Full, 2nd round) | February 15, 2027 (LOI, 1st round, next) | April 15, 2027 (Full, 1st round, next)
Funding Amounts: Up to $125,000 per year for 1–2 years; larger budgets considered if well justified.
Summary: Supports investigator-led basic, translational, or clinical research advancing knowledge or therapy development in Friedreich’s ataxia.
The Friedreich's Ataxia Research Alliance (FARA) General Research Grant funds innovative projects that advance understanding or treatment of Friedreich’s ataxia (FA). The program welcomes proposals spanning basic, translational, and clinical research, provided they align with FARA’s research priorities. The grant aims to accelerate progress toward effective therapies by supporting a diverse range of scientific approaches and fostering collaboration among investigators.